Home Tags Tissue factor

Tag: tissue factor

ESMO 2020: Study Shows Meaningful Clinical Activity with Tisotumab Vedotin ...

Tisotumab vedotin, an investigational agent is being developed by Seattle Genetics and Genmab, shows meaningful clinical activity as monotherapy in patients with previously treated...

Zymeworks Signs Licensing Agreement with Iconic Therapeutics

Canada-based Zymeworks, a clinical-stage biopharmaceutical company, has entered into a licensing agreement that grants Iconic Therapeutics non-exclusive rights to the company's proprietary ZymeLink™ antibody-drug...

Phase II Trial of Tisotumab Vedotin in Advanced Cervical Cancer Provides...

Genmab and Seattle Genetics confirmed their decision to start a Phase II study of tisotumab vedotin in patients with recurrent and/or metastatic cervical cancer....
pancreatic cancer cells

Fab’-installed Polymeric Micelles Significantly Improve Efficient Drug Delivery to Solid Tumors

To enhance the efficacy of unconjugated antibodies, researchers have optimized their antitumor activity by conjugating them with radionuclides, toxins, or cytotoxic drugs. The choice...